Cita APA

Jencquel, C., Bruni, S., Dupont, A., Mauro, F. L., Schillaci, R., & Mercogliano, M. F. (2024). Soluble TNFα blockade enhances tras tuzumab-deruxtecan antitumor effect in HER2+ breast cancer. Web

Citación estilo Chicago

Jencquel, Camila, Sofia Bruni, Agustina Dupont, Florencia Luciana Mauro, Roxana Schillaci, and María Florencia Mercogliano. Soluble TNFα Blockade Enhances Tras Tuzumab-deruxtecan Antitumor Effect in HER2+ Breast Cancer. 2024.

Cita MLA

Jencquel, Camila, et al. Soluble TNFα Blockade Enhances Tras Tuzumab-deruxtecan Antitumor Effect in HER2+ Breast Cancer. 2024.